Today on the Medscape Medical Minute: New data show that semaglutide improves kidney function in patients who have overweight or obesity without type 2 diabetes; an FDA panel concludes that the benefits of weekly insulin do not outweigh the risks; and Italy undertakes nationwide screening of children for celiac disease. https://www.medscape.com/viewarticle/989872